Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank40
3Y CAGR-11.0%
5Y CAGR+44.0%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-11.0%/yr
Annual compound
5Y CAGR
+44.0%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
6.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$111.00M-17.4%
2023$134.34M+3.9%
2022$129.31M-17.9%
2021$157.53M+70.2%
2020$92.57M+417.3%
2019$17.90M-